PVCT
Vanguard Group’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,693,146
| Closed | -$366K | – | 4140 |
|
|
2016
Q3 | $366K | Sell |
3,693,146
-37,032
| -1% | -$3.67K | ﹤0.01% | 3814 |
|
|
2016
Q2 | $1.38M | Buy |
3,730,178
+5,800
| +0.2% | +$2.15K | ﹤0.01% | 3510 |
|
|
2016
Q1 | $1.41M | Buy |
3,724,378
+464,700
| +14% | +$176K | ﹤0.01% | 3492 |
|
|
2015
Q4 | $1.27M | Buy |
3,259,678
+102,101
| +3% | +$39.8K | ﹤0.01% | 3548 |
|
|
2015
Q3 | $1.82M | Buy |
3,157,577
+58,421
| +2% | +$33.6K | ﹤0.01% | 3419 |
|
|
2015
Q2 | $1.67M | Hold |
3,099,156
| – | – | ﹤0.01% | 3482 |
|
|
2015
Q1 | $2.53M | Hold |
3,099,156
| – | – | ﹤0.01% | 3311 |
|
|
2014
Q4 | $2.48M | Buy |
3,099,156
+137,900
| +5% | +$110K | ﹤0.01% | 3202 |
|
|
2014
Q3 | $3.02M | Buy |
+2,961,256
| New | +$3.02M | ﹤0.01% | 3097 |
|